Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Saudi Arabia

Inflationary Concerns Lead To Pharmaceutical Pricing Curbs

November 2007 | Industry News

Following the government's announcement in September that it would act to reduce the price of medicines in Saudi Arabia, Minister of Health Dr Hamad Al-Manea has spelt out how this will be achieved. Drugs, generic or patented, that were first registered with the Ministry of Health five or more years ago will come under new regulations and see their prices cut by 1%. Newer drugs will have their prices

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Bupa Arabia Launches IPO

Industry / Saudi Arabia In a bid to raise capital for new services, Bupa Arabia, part of the UK's Bupa health insurance group has launched an initial public offering (IPO) on the Saudi Stock Exchange (Tadawul). As part of the...
March 2008
Bupa Arabia Launches IPO

Industry / Saudi Arabia In a bid to raise capital for new services, Bupa Arabia, part of the UK's Bupa health insurance group has launched an initial public offering (IPO) on the Saudi Stock Exchange (Tadawul). As part of the...
March 2008
Shift Towards Private Health Provides Investment Opportunity

Companies / Saudi Arabia Saudi Arabia's drug market could offer a strong investment opportunity over the next five years, as a number of factors come together to drive up medicine consumption.
February 2007
Private Healthcare On The March

Companies / Saudi Arabia Saudi Arabia's public healthcare spending should fall to 50% of total expenditure over the next three years as the new private medical scheme for expatriate workers comes into effect. The private sector's...
February 2007
GCC Spends More On SGH Tender

Companies / Saudi Arabia The Gulf Co-operation Council (GCC)'s joint tender for drugs and healthcare products was worth US$665mn in 2006, according to official reports, an increase of US$84.5mn over 2005 levels. Out of this...
January 2007


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS